{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:58:26Z","timestamp":1781567906856,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases","award":["2014NXGZ01"],"award-info":[{"award-number":["2014NXGZ01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1002\/jps.24604","type":"journal-article","created":{"date-parts":[[2015,8,3]],"date-time":"2015-08-03T21:15:44Z","timestamp":1438636544000},"page":"3960-3967","source":"Crossref","is-referenced-by-count":38,"title":["Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients"],"prefix":"10.1016","volume":"104","author":[{"given":"Xingang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghui","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.24604_bb0005","first-page":"21","article-title":"Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society Of Infectious Diseases Pharmacists","volume":"31","author":"Martin","year":"2010","journal-title":"Clin Biochem Rev"},{"key":"10.1002\/jps.24604_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1002\/jps.24604_bb0015","first-page":"393","article-title":"Risk factors for neurosurgical site infections after a neurosurgical procedure: A prospective observational study at Hospital Kuala Lumpur","volume":"67","author":"Buang","year":"2012","journal-title":"Med J Malaysia"},{"key":"10.1002\/jps.24604_bb0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","article-title":"Practice guidelines for the management of bacterial meningitis","volume":"39","author":"Tunkel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.24604_bb0025","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40272-013-0017-5","article-title":"Pharmacokinetics of antibacterial agents in the CSF of children and adolescents","volume":"15","author":"Sullins","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1002\/jps.24604_bb0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.surneu.2007.01.073","article-title":"Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients","volume":"69","author":"Wang","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1002\/jps.24604_bb0035","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00381-013-2333-z","article-title":"Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: A systematic review","volume":"30","author":"Drew","year":"2014","journal-title":"Childs Nerv Syst"},{"key":"10.1002\/jps.24604_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12028-012-9784-z","article-title":"Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults","volume":"20","author":"Ng","year":"2014","journal-title":"Neurocrit Care"},{"key":"10.1002\/jps.24604_bb0045","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1212\/01.wnl.0000203120.85850.54","article-title":"Axonal damage markers in cerebrospinal fluid are increased in ALS","volume":"66","author":"Brettschneider","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/jps.24604_bb0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"key":"10.1002\/jps.24604_bb0055","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jps.23763","article-title":"Population pharmacokinetics of rilotumumab, a fully human monoclonal antibody against hepatocyte growth factor, in cancer patients","volume":"103","author":"Zhu","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.24604_bb0060","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/aps.2012.33","article-title":"Pharmacokinetic\/pharmacodynamic studies on exenatide in diabetic rats","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"10.1002\/jps.24604_bb0065","unstructured":"Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). September 2013. Accessed May 24, 2015, at: http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm064964.htm."},{"key":"10.1002\/jps.24604_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11596390-000000000-00000","article-title":"Vancomycin: A review of population pharmacokinetic analyses","volume":"51","author":"Marsot","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.24604_bb0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10928-014-9358-0","article-title":"Population pharmacokinetics of intravenous acetaminophen and its metabolites in major surgical patients","volume":"41","author":"Owens","year":"2014","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1002\/jps.24604_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.diagmicrobio.2009.11.008","article-title":"Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years","volume":"66","author":"Appleman","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1002\/jps.24604_bb0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2710.2008.01016.x","article-title":"Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type","volume":"34","author":"Yamamoto","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1002\/jps.24604_bb0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s40262-014-0164-z","article-title":"Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis","volume":"53","author":"Mangin","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.24604_bb0095","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/jac\/dkp085","article-title":"Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations","volume":"63","author":"Thomson","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1002\/jps.24604_bb0100","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2710.2006.00762.x","article-title":"Population pharmacokinetic parameters of vancomycin in critically ill patients","volume":"31","author":"Llopis-Salvia","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1002\/jps.24604_bb0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5414\/CPP48525","article-title":"Population pharmacokinetics of vancomycin in adult and geriatric patients: Comparison of eleven approaches","volume":"48","author":"S\u00e1nchez","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1002\/jps.24604_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2125.2005.02432.x","article-title":"Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation","volume":"60","author":"Mulla","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/jps.24604_bb0115","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/515003","article-title":"Antibiotic pharmacodynamics in cerebrospinal fluid","volume":"27","author":"Lutsar","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1002\/jps.24604_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-8-7","article-title":"Drug transport in brain via the cerebrospinal fluid","volume":"8","author":"Pardridge","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.1002\/jps.24604_bb0125","first-page":"617","article-title":"The efficacy of intraventricularly administered vancomycin in the case of central nervous system infection caused by Enterococcus faecalis","volume":"55","author":"Czaban","year":"2002","journal-title":"Wiad Lek"},{"key":"10.1002\/jps.24604_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnins.2015.00021","article-title":"Efflux transporters in bloodbrain interfaces of the developing brain","volume":"9","author":"Strazielle","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1002\/jps.24604_bb0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40262-015-0241-y","article-title":"Drug transporters in the central nervous system","volume":"54","author":"Stieger","year":"2015","journal-title":"Clin Pharmacokinet"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916301836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916301836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:05:07Z","timestamp":1565265907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916301836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0022354916301836"],"URL":"https:\/\/doi.org\/10.1002\/jps.24604","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}